Cultivated meat firm calls 200-L trial a success, hopes to commercialize by 2025.
Shanghai-based CellX has announced that its first production trial of suspended cultured fish cells in a 200-litre bioreactor was a success.
The test run follows the completion last month of the company’s pilot plant, which contains multiple 1,000-litre bioreactors.
“We are confident that through continuous technological iteration, we can achieve cost-effective mass production of cultivated fish…
Join for free* to continue reading.
You’ll get access to all Alt-Meat has to offer including full access to our web content devoted to the meat alternatives market.
Already a member? Click here to login>>.
*Free for qualified recipients